Human Pancreatic Lipase (PNLIP) activation kit by CRISPRa

CAT#: GA103636

PNLIP CRISPRa kit - CRISPR gene activation of human pancreatic lipase



Find the corresponding CRISPRi Inhibitor Kit

Product Images

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol PNLIP
Locus ID 5406
Kit Components

GA103636G1, Pancreatic Lipase gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA103636G2, Pancreatic Lipase gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA103636G3, Pancreatic Lipase gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_000936
UniProt ID P16233
Synonyms PL; PNLIPD; PTL
Summary This gene encodes a member of the lipase family of proteins. The encoded enzyme is secreted by the pancreas and hydrolyzes triglycerides in the small intestine, and is essential for the efficient digestion of dietary fats. Inhibition of the encoded enzyme may prevent high-fat diet-induced obesity in mice and result in weight loss in human patients with obesity. Mutations in this gene cause congenital pancreatic lipase deficiency, a rare disorder characterized by steatorrhea. [provided by RefSeq, Jul 2016]

Documents

Other Versions